Pancreatic Cancer Research

ResearcherAsan Medical CenterNo recent work listed

Mi‐Ju Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8467-8999; OpenAlex author ID A5000177690. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis. Co-author DOI 10.1073/pnas.2119048119↗
  2. Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients. Co-author DOI 10.1186/s12935-017-0416-8↗
  3. Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.1016/j.yexcr.2015.05.017↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seung‐Mo Hong · 3 shared papers, 2015–2022 · strength 0.23
  2. Suhwan Chang · 2 shared papers, 2017–2022 · strength 0.18
  3. Song Cheol Kim · 2 shared papers, 2017–2022 · strength 0.18
  4. Eun Ah Choi · 1 shared paper, 2022 · strength 0.12
  5. Yeon‐Sook Choi · 1 shared paper, 2022 · strength 0.12
  6. Yeon Wook Kim · 1 shared paper, 2022 · strength 0.12
  7. Jae Yun Jung · 1 shared paper, 2022 · strength 0.12
  8. Hosub Park · 1 shared paper, 2017 · strength 0.06
  9. Kyu‐pyo Kim · 1 shared paper, 2017 · strength 0.06
  10. Dae Wook Hwang · 1 shared paper, 2017 · strength 0.06
  11. Sung Joo Kim · 1 shared paper, 2017 · strength 0.06
  12. Dong Joon Kim · 1 shared paper, 2015 · strength 0.04
  13. Young Il Yeom · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.